Veranova
Mike Riley has a diverse work experience spanning several companies. Mike is currently the Chief Executive Officer at Veranova, starting in May 2023. Prior to that, they held various leadership roles at Catalent Pharma Solutions from 2004 to 2021. These roles included President, Biotherapeutics; President - Biologics North America; Vice President/General Manager, Catalent Biologics; Vice President Strategy, Advanced Delivery Technologies; Vice President, Global Sales and Business Development; and Director, Business Development. Before joining Catalent, they worked as a Consultant at Marakon Associates from 1998 to 2002.
Mike Riley earned a Bachelor of Arts (BA), Magna Cum Laude degree from Duke University, where they attended from 1994 to 1998. Mike later pursued their MBA at The Wharton School from 2002 to 2004.
This person is not in any offices
Veranova
2 followers
Veranova is a representative in the research and production of sophisticated and complex active pharmaceutical ingredients and APIs for the pharmaceutical and biotech industries. They test their scientific expertise and diversified talent as they investigate and create fresh approaches to resolving business issues while enhancing value for itsstakeholders and consumers.